DrugPatentWatch Database Preview
NATPARA Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: NATPARA
| Patents: | 1009 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for NATPARA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NATPARA |
Recent Clinical Trials for NATPARA
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Entera Bio Ltd. | Phase 2 |
| Shire | Phase 1 |
| Haukeland University Hospital | Phase 0 |
Recent Litigation for NATPARA
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Genentech, Inc. v. Pfizer Inc. | 2019-04-05 |
| Genentech, Inc. v. Immunex Rhode Island Corp. | 2019-03-29 |
| Genentech, Inc. v. Samsung Bioepis Co., Ltd. | 2018-09-04 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Pfizer, Inc. | 2017-05-19 |
Pharmacology for NATPARA
| Ingredient-type | Parathyroid Hormone |
Company Disclosures: US Patents for NATPARA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Allelix BioPharmaceuticals Inc. (Ontario, CA) | 2039-03-29 | RX | Orphan | company |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | Allelix BioPharmaceuticals Inc. (Ontario, CA) | 2039-03-29 | RX | Orphan | company |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | Allelix BioPharmaceuticals Inc. (Ontario, CA) | 2039-03-29 | RX | Orphan | company |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Allelix BioPharmaceuticals Inc. (Ontario, CA) | 2039-03-29 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for NATPARA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) | 2031-06-07 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Novartis AG (Basel, CH) | 2032-03-30 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | ASCENDIS PHARMA A/S (Hellrup, DK) | 2024-07-05 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2033-02-15 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for NATPARA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20110124806 | Start Trial |
| Norway | 313080 | Start Trial |
| Australia | 2002359338 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0219969 | Start Trial |
| Germany | 602006003228 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for NATPARA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 122014000025 | Germany | Start Trial | PRODUCT NAME: GLYCOPYRRONIUM ODER EIN SALZ ODER DERIVAT HIERVON (KOMPONENTE 1) UND INDACATEROL ODER EIN DERIVAT HIERVON ODER EIN SALZ VON INDACATEROL ODER EINEM DERIVAT HIERVON (KOMPONENTE 2); REGISTRATION NO/DATE: EU/1/13/862 20130919 |
| SPC/GB10/045 | United Kingdom | Start Trial | PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR)) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526 |
| CA 2014 00020 | Denmark | Start Trial | PRODUCT NAME: GLYCOPYRRONIUM ELLER ET SALT DERAF, ISAER BROMIDSALTET, I KOMBINATION MED INDACATEROL ELLER ET SALT DERAF, ISAER MALEATSALTET; REG. NO/DATE: EU/1/13/862 20130919 |
| 496 | Finland | Start Trial | |
| 122013000029 | Germany | Start Trial | PRODUCT NAME: GLYKOPYRRONIUM ODER EIN SALZ ODER DERIVAT HIERVON; REGISTRATION NO/DATE: EU/1/12/788/001-006 20120928 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
